Maintenance Notice (3:00 AM - 8:30 AM December 13, 10:30 PM December 13 - 12:40 AM December 14 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.200 | Product Document Searching Made Easy by 2D Code! | TCI Life Science News December 2025 | [Product Highlights] Catechol-containing Methacrylate Monomer for... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 71369-59-0 | 產品號碼: T4139
(-)-Talinolol
×
| 包裝 | 價格 | 同一天 | 2-3个工作日 | 左側以上貨期 |
貨期資訊
|
|---|---|---|---|---|---|
| 20MG |
NT$5,376
|
12 | 19 | 下單後約2週內可以出貨 |
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | T4139 |
純度/分析方法 
|
>95.0%(T)(HPLC) |
| 分子式 / 分子量 | C__2__0H__3__3N__3O__3 = 363.50 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Refrigerated (0-10°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Air Sensitive,Heat Sensitive |
| CAS RN | 71369-59-0 |
| 相關CAS RN
|
57460-41-0 |
| Reaxys-RN | 8353028 |
產品規格
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| Melting point | 142.0 to 146.0 °C |
| Specific rotation | -9.0 to -11.0 deg(C=0.1, methanol) |
| NMR | confirm to structure |
性質
| 熔點 | 144 °C |
GHS
相關法規
運輸資料
| HS編碼* | 2924.21-000 |
Application
(-)-Talinolol: A Model Compound for P-Glycoprotein Drug-Drug Interaction Studies
(±)-Talinolol, a β1-selective adrenoceptor antagonist, has been used as a suitable model compound for P-glycoprotein drug-drug interaction studies due to its P-glycoprotein-related active intestinal secretion and lack of any significant metabolism.1,2) (-)-Talinolol is the active (S)-isomer as a β1-selective adrenoceptor antagonist, and can also be used as a model compound for the studies.3,4) (The product is for research purpose only.)
References
- 1) Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction
- 2) P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans
- 3) Evidence for intestinal secretion as an additional clearance pathway of talinolol enantiomers: concentration- and dose-dependent absorption in vitro and in vivo
- 4) Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol (a review)
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。